Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(44)
•••
Dudeforever
X
View Profile
View Bullboard History
Comment by
Dudeforever
on Dec 30, 2020 3:16pm
RE:RE:No more volume
I believe the purchasers of the PP cannot sell for four months as per their agreement.
(54)
•••
bullbear007
X
View Profile
View Bullboard History
Comment by
bullbear007
on Dec 30, 2020 3:01pm
RE:No more volume
Needs to go back to the 0.30 that was available to the PP. they will not be happy with earning only 0.30 / share if the price is higher. Sold at the peak yesterday and will wait for it to come back to
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Nov 30, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(442)
•••
averylamberson
X
View Profile
View Bullboard History
Post by
averylamberson
on Dec 30, 2020 1:53pm
Progress to Cure
What exactly expected to be sustained throughout the 2020s? Unexpected progress might be here! There is no one-shoe-fits-all approach to treating ASD. However, these other
...more
(79)
•••
Pimpovish
X
View Profile
View Bullboard History
Post by
Pimpovish
on Dec 30, 2020 1:44pm
Penile block at 70 cents is interesting
Thats not necessarily someone looking to sell but more likely someone who wants to put a cap on the share price. A lot of possibilities come to mind...
(149)
•••
GarlicToast
X
View Profile
View Bullboard History
Comment by
GarlicToast
on Dec 30, 2020 12:21pm
RE:No more volume
The volume here was sheer cr@ap for day traders and flippers only. Glad this hppen now the real investors with patience will step in and make a killing. -GT fug123 - (12/30/2020 11:03:49
...more
(95)
•••
Walterthedog
X
View Profile
View Bullboard History
Comment by
Walterthedog
on Dec 30, 2020 11:46am
RE:No more volume
Just have to wait a few weeks for midpoint data and PP to close. I'm sure when they release the data they will update as to when they expect the phase 2 trial to be complete which will be a major
...more
(9)
•••
fug123
X
View Profile
View Bullboard History
Post by
fug123
on Dec 30, 2020 11:03am
No more volume
Someone made a nice profit from this stock. Time to move on. Hope I'm wrong, but I have a feeling it's a free fall from here.
(79)
•••
Pimpovish
X
View Profile
View Bullboard History
Post by
Pimpovish
on Dec 30, 2020 10:53am
Someone pointed out SVA—Sernova Corp
SVA--$142 million marketcap. This is a lesser evolved company and its running hot. They have currently enrolled 5 patients for clinical trials. Their tech is based on cellular transplantation. HEM
...more
(1)
•••
THORZEUS2019
X
View Profile
View Bullboard History
Comment by
THORZEUS2019
on Dec 30, 2020 10:32am
RE:LOOKS LIKE -
Profit taking..The PP is at $0.30...what do you expect
(183)
•••
milstogo
X
View Profile
View Bullboard History
Post by
milstogo
on Dec 30, 2020 9:58am
LOOKS LIKE -
A nice start for the day!
(20)
•••
Bob002
X
View Profile
View Bullboard History
Post by
Bob002
on Dec 30, 2020 8:52am
Launching In Green Leaf
Everybody should take at any rate one major swing throughout everyday life. Might need this too It is said that These other companies are racing to meet green leaf demand with its proprietary
...more
(149)
•••
GarlicToast
X
View Profile
View Bullboard History
Post by
GarlicToast
on Dec 30, 2020 8:23am
HEM Quote as of: Dec 30, 2020 08:22:01 AM ET $2.01
QUOTE FORHEMOSTEMIX INC Refresh CURRENT PRICE IS0.035(unchanged from previous) PRICE CHANGE+0.00 PRICE CHANGE0.00% Bid Size
...more
(1)
•••
newstart2021
X
View Profile
View Bullboard History
Comment by
newstart2021
on Dec 30, 2020 7:50am
RE:Open at 1.06
*UP* (CSE) big buying recently based on rumours they are becoming a blockchain company. It trades at $0.015 with larger volume over the past weeks.
(111)
•••
Ravens1
X
View Profile
View Bullboard History
Post by
Ravens1
on Dec 30, 2020 7:47am
Open at 1.06
currently open at 1.06
(111)
•••
Ravens1
X
View Profile
View Bullboard History
Comment by
Ravens1
on Dec 30, 2020 7:10am
RE:RE:Whats it worth?—a calculated approach
So guys I read a lot yesterday on them snd watched videos. this one looks to have great future. $7/ share is way too high in my opinion but let them have a first contract and we will see. From
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >